Northern Trust
TSHA icon

Northern Trust’s Taysha Gene Therapies TSHA Stock Holding History

Northern Trust’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
2,226,210
+411,892
+23% +$2.44M ﹤0.01% 1951
2026
Q1 		$8.11M Buy
1,814,318
+576,331
+47% +$2.68M ﹤0.01% 2192
2025
Q4 		$6.81M Sell
1,237,987
-479,191
-28% -$2.33M ﹤0.01% 2294
2025
Q3 		$5.62M Buy
1,717,178
+388,437
+29% +$1.1M ﹤0.01% 2432
2025
Q2 		$3.07M Sell
1,328,741
-102,925
-7% -$224K ﹤0.01% 2757
2025
Q1 		$1.99M Sell
1,431,666
-27,066
-2% -$45.3K ﹤0.01% 2927
2024
Q4 		$2.52M Buy
1,458,732
+86,207
+6% +$179K ﹤0.01% 2895
2024
Q3 		$2.76M Buy
1,372,525
+1,101,759
+407% +$2.42M ﹤0.01% 2798
2024
Q2 		$607K Buy
270,766
+59,371
+28% +$173K ﹤0.01% 3437
2024
Q1 		$607K Sell
211,395
-2,326
-1% -$4.85K ﹤0.01% 3499
2023
Q4 		$378K Buy
213,721
+147,531
+223% +$294K ﹤0.01% 3642
2023
Q3 		$209K Sell
66,190
-6,768
-9% -$12.6K ﹤0.01% 3800
2023
Q2 		$48.2K Hold
72,958
– – ﹤0.01% 4228
2023
Q1 		$58.2K Hold
72,958
– – ﹤0.01% 4226
2022
Q4 		$165K Buy
72,958
+33,031
+83% +$66.9K ﹤0.01% 3948
2022
Q3 		$77K Buy
39,927
+1,106
+3% +$4.01K ﹤0.01% 4204
2022
Q2 		$144K Sell
38,821
-166,804
-81% -$662K ﹤0.01% 4044
2022
Q1 		$1.34M Sell
205,625
-9,345
-4% -$69.9K ﹤0.01% 3286
2021
Q4 		$2.5M Buy
214,970
+3,042
+1% +$45.9K ﹤0.01% 3115
2021
Q3 		$3.95M Buy
211,928
+13,069
+7% +$248K ﹤0.01% 2880
2021
Q2 		$4.22M Buy
198,859
+101,935
+105% +$2.35M ﹤0.01% 2952
2021
Q1 		$1.97M Sell
96,924
-6,334
-6% -$171K ﹤0.01% 3251
2020
Q4 		$2.74M Buy
+103,258
New +$2.22M ﹤0.01% 3026

Other funds holding TSHA

Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust's TSHA Position: Q2 2026 in Review

Northern Trust increased its Taysha Gene Therapies (TSHA) stake by 23% in Q2 2026, buying an estimated $2.44M and bringing the position to 2,226,210 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

Northern Trust first reported a position in TSHA in Q4 2020 and has held it in 23 quarters since. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Northern Trust held 2,226,210 shares of Taysha Gene Therapies worth $15.2M as of Q2 2026.
  • Northern Trust bought 411,892 Taysha Gene Therapies shares in Q2 2026, an estimated $2.44M.
  • Taysha Gene Therapies made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1951 holding.
  • Northern Trust first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 23 quarters since.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.